IRIS
BIANCONI, MARISTELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.387
EU - Europa 1.453
AS - Asia 1.210
SA - Sud America 376
AF - Africa 104
Continente sconosciuto - Info sul continente non disponibili 102
OC - Oceania 1
Totale 6.633
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.294
SG - Singapore 405
IT - Italia 330
BR - Brasile 310
CN - Cina 224
VN - Vietnam 224
RU - Federazione Russa 205
UA - Ucraina 200
DE - Germania 129
SE - Svezia 129
TR - Turchia 112
IE - Irlanda 107
FI - Finlandia 82
DK - Danimarca 75
HK - Hong Kong 74
FR - Francia 69
GB - Regno Unito 64
KR - Corea 42
CA - Canada 41
CI - Costa d'Avorio 38
IN - India 36
MA - Marocco 28
BD - Bangladesh 27
MX - Messico 21
AR - Argentina 20
ZA - Sudafrica 17
NL - Olanda 15
JP - Giappone 14
ES - Italia 13
CO - Colombia 11
EC - Ecuador 10
ID - Indonesia 10
BE - Belgio 8
CL - Cile 8
PL - Polonia 8
VE - Venezuela 8
HN - Honduras 7
IQ - Iraq 7
MY - Malesia 7
CR - Costa Rica 6
DZ - Algeria 6
GT - Guatemala 6
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
EU - Europa 4
PK - Pakistan 4
UY - Uruguay 4
BG - Bulgaria 3
CZ - Repubblica Ceca 3
KE - Kenya 3
LT - Lituania 3
RS - Serbia 3
SA - Arabia Saudita 3
SC - Seychelles 3
SV - El Salvador 3
AT - Austria 2
AZ - Azerbaigian 2
CW - ???statistics.table.value.countryCode.CW??? 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GP - Guadalupe 2
GR - Grecia 2
JM - Giamaica 2
JO - Giordania 2
KZ - Kazakistan 2
PE - Perù 2
PH - Filippine 2
PY - Paraguay 2
UZ - Uzbekistan 2
AO - Angola 1
BN - Brunei Darussalam 1
BO - Bolivia 1
EG - Egitto 1
IM - Isola di Man 1
KG - Kirghizistan 1
LB - Libano 1
MD - Moldavia 1
MT - Malta 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TV - Tuvalu 1
Totale 6.537
Salva come PNG Salva come JPEG
Città #
Ashburn 589
Singapore 252
Chandler 236
Fairfield 217
Jacksonville 207
Dallas 156
San Jose 154
Wilmington 137
Council Bluffs 110
Dublin 107
Seattle 99
Centro 96
Boardman 94
New York 85
Woodbridge 83
Houston 78
Ho Chi Minh City 72
Hong Kong 70
Ann Arbor 69
Beijing 63
Cambridge 59
Hanoi 58
Los Angeles 55
Des Moines 51
Princeton 50
Moscow 48
Turin 45
Lawrence 43
San Mateo 43
Lauterbourg 38
Abidjan 37
The Dalles 36
Munich 29
Helsinki 23
Orem 21
Turku 21
São Paulo 20
Milan 19
Chicago 18
London 18
San Diego 18
Atlanta 15
Hefei 15
Santa Clara 14
Tokyo 14
Buffalo 13
Chennai 13
Johannesburg 11
Montreal 11
Pune 10
Rio de Janeiro 10
Columbus 9
Frankfurt am Main 9
Izmir 9
Stockholm 9
Amsterdam 8
Brasília 8
Brussels 8
Paris 8
Belo Horizonte 7
Da Nang 7
Manchester 7
Poplar 7
Cagliari 6
Denver 6
Miano 6
Norwalk 6
Porto Alegre 6
Rome 6
San Francisco 6
Santiago 6
Shanghai 6
Toronto 6
Warsaw 6
Wuxi 6
Brooklyn 5
Bến Tre 5
Campinas 5
Curitiba 5
Dhaka 5
Fayetteville 5
Fortaleza 5
Guangzhou 5
Guatemala City 5
Guayaquil 5
Kilburn 5
Mexico City 5
San José 5
Washington 5
Wuhan 5
Biên Hòa 4
Bogotá 4
Bắc Giang 4
Duque de Caxias 4
Goiânia 4
Grand Rapids 4
Guarulhos 4
Haiphong 4
Irving 4
Madrid 4
Totale 4.133
Salva come PNG Salva come JPEG
Nome #
Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy 227
Immunotherapy in genitourinary cancers: Where are we going? 216
The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment 207
Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients. 205
The role of Aspirin as antitumoral agent for heavily pre-treated metastatic colorectal cancer patients receiving capecitabine monotherapy. BMC Cancer 204
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients 199
A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer. 196
Il profilo angiogenico nel carcinoma renale metastatico: implicazioni prognostiche e terapeutiche 181
The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy 179
Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study 175
Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New 172
VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study 171
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab. 170
Neutrophil‑to‑lymphocyte ratio may be associated with the outcome in patients with prostate cancer 167
CANCER STEM CELL GENETIC PROFILE AS PREDICTOR OF RELAPSE IN RADICALLY RESECTED COLORECTAL CANCER 166
Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients. 163
Adjuvant treatment after surgical resection 163
Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: Implications for clinical management 162
Contemporary best practice in the management of urothelial carcinomas of the renal pelvis and ureter 162
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in clear cell renal cell carcinoma patients 161
Panitumumab for the treatment of metastatic colorectal cancer: A review 156
Clinical evidence for three distinct gastric cancer subtypes: time for a new approach. 151
Dalotuzumab, a recombinant humanized mAb targeted against IGFR1 for the treatment of cancer. 150
The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management. 148
Beyond RAS: the role of epidermal growth factor receptor (EGFR) and its network in the prediction of clinical outcome during anti-EGFR treatment in colorectal cancer patients 147
Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients. 145
The "angiogenetic ladder", step-wise angiogenesis inhibition in metastatic colorectal cancer 144
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib 143
Molecular biomarkers of resistance to anti-EGFR treatment in metastatic colorectal cancer, from classical to innovation. 143
Prognostic Value for Incidental Antihypertensive Therapy With β-Blockers in Metastatic Colorectal Cancer 142
Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma 141
Three drugs vs two drugs first-line chemotherapy regimen in advanced gastric cancer patients: a retrospective analysis 138
Role of β4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximab. 138
The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management 135
The role of tumor vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) polymorphisms in the prediction of clinical outcome for advanced renal cell carcinoma patients receiving first-line sunitinib 134
Selected gastrointestinal cancer presentations from the American Society of Clinical Oncology annual meeting 2013 in review: It is not about the destination, it is about the journey 123
The Tower of Babel of liver metastases from colorectal cancer: Are we ready for one language? 113
VEGF expression and response to sunitinib in patients with metastatic clear cell renal cell carcinoma 113
Protracted low doses of temozolomide for the treatment of patients with recurrent glioblastoma: A phase II study. 112
The Role of Aspirin as Antitumoral Agent for Heavily Pretreated Patients With Metastatic Colorectal Cancer Receiving Capecitabine Monotherapy 101
Selected news from the 2014 Genitourinary Cancers Symposium: Translating novel strategies into clinical practice 97
State of the art and future perspectives for the use of insulin-like growth factor receptor 1 (IGF-1R) targeted treatment strategies in solid tumors. 96
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in clear cell renal cell carcinoma 77
Totale 6.633
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.253
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.253
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022239 0 0 0 5 2 19 21 22 18 53 29 70
2022/2023727 53 98 59 48 47 114 1 38 166 3 83 17
2023/2024364 61 2 29 45 54 93 6 11 1 6 8 48
2024/2025833 112 74 10 12 47 29 120 32 139 62 109 87
2025/20262.337 158 226 166 236 293 170 357 199 165 212 55 100
2026/2027392 89 59 79 165 0 0 0 0 0 0 0 0
Totale 6.633